Our Experience

A highly experienced CNS-dedicated research site with 25+ years of continuous industry-sponsored clinical trial experience.

150+
Clinical Trials Completed
25+
Years CNS Research Experience
3,000+
CNS Patient Database

CNS Trials by Indication

149 total trials completed across psychiatric and neurological conditions

Alzheimer's / Dementia

77

Trials Completed

51% of total

Schizophrenia

27

Trials Completed

18% of total

Major Depressive Disorder

12

Trials Completed

8% of total

Bipolar Disorder

7

Trials Completed

5% of total

Migraine / Neurology

4

Trials Completed

3% of total

Obsessive Compulsive Disorder

3

Trials Completed

2% of total

Parkinson's Disease

3

Trials Completed

2% of total

Other CNS Indications

16

Trials Completed

11% of total

Trusted by Leading Pharmaceutical Companies

Partnerships with the world's most innovative pharmaceutical and biotech companies

Johnson & Johnson
Pfizer
Roche
Eli Lilly
Novartis
Bristol Myers Squibb
Boehringer Ingelheim
Eisai
Otsuka
Merck
GlaxoSmithKline
AstraZeneca
Allergan
Biohaven
Acadia
Neurocrine
Sunovion
Karuna
Lundbeck
Celgene

...and 55+ more pharmaceutical partners

Studies by Indication

Comprehensive experience across diverse medical conditions

Partner With Experience

Join the leading pharmaceutical companies who trust Galiz Research for their clinical trials.